Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The closing price of Terns Pharmaceuticals Inc (NASDAQ: TERN) was $4.46 for the day, down -1.55% from the previous closing price of $4.53. In other words, the price has decreased by -$1.55 from its previous closing price. On the day, 1.19 million shares were traded. TERN stock price reached its highest trading level at $4.58 during the session, while it also had its lowest trading level at $4.41.
Ratios:
Our analysis of TERN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 32.99 and its Current Ratio is at 32.99. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on October 31, 2024, initiated with a Outperform rating and assigned the stock a target price of $82.
On June 22, 2023, Mizuho started tracking the stock assigning a Buy rating and target price of $16.
On June 07, 2023, Jefferies started tracking the stock assigning a Buy rating and target price of $18.Jefferies initiated its Buy rating on June 07, 2023, with a $18 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 02 ’25 when Kuriakose Emil sold 4,481 shares for $5.71 per share. The transaction valued at 25,607 led to the insider holds 54,269 shares of the business.
Vignola Mark J. sold 9,059 shares of TERN for $52,500 on Jan 06 ’25. The Chief Financial Officer now owns 74,752 shares after completing the transaction at $5.80 per share. On Jan 02 ’25, another insider, Vignola Mark J., who serves as the Chief Financial Officer of the company, sold 8,129 shares for $5.72 each. As a result, the insider received 46,524 and left with 83,811 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TERN now has a Market Capitalization of 378827488 and an Enterprise Value of 7257708.
Stock Price History:
The Beta on a monthly basis for TERN is -0.35, which has changed by -0.12548262 over the last 52 weeks, in comparison to a change of 0.25219524 over the same period for the S&P500. Over the past 52 weeks, TERN has reached a high of $11.40, while it has fallen to a 52-week low of $4.32. The 50-Day Moving Average of the stock is -22.48%, while the 200-Day Moving Average is calculated to be -35.26%.
Shares Statistics:
TERN traded an average of 1.70M shares per day over the past three months and 1749390 shares per day over the past ten days. A total of 84.92M shares are outstanding, with a floating share count of 62.32M. Insiders hold about 26.63% of the company’s shares, while institutions hold 71.64% stake in the company. Shares short for TERN as of 1736899200 were 7638295 with a Short Ratio of 4.49, compared to 1734048000 on 6204533. Therefore, it implies a Short% of Shares Outstanding of 7638295 and a Short% of Float of 9.879999999999999.
